Cancer research and drug development by Kura Oncology
Kura Oncology reveals first results in AML combination therapy at upcoming conference
Kura Oncology announced it will present several abstracts at the 68th American Society of Hematology (ASH) Annual Meeting. The company, in collaboration with Kyowa Kirin, will unveil new clinical ...
Kura Oncology to present new clinical data on combination therapies for acute myeloid leukemia at 68th ASH meeting
Kura Oncology announced it will share several new abstracts at the 68th American Society of Hematology (ASH) Annual Meeting. The presentations, in collaboration with Kyowa Kirin, will include ...
Kura Oncology launches clinical study for farnesyl transferase inhibitor combination therapy
Kura Oncology has begun actively enrolling adults with advanced clear cell renal cell carcinoma for its FIT-001 Phase 1 clinical trial. The Phase 1b portion of the trial will evaluate an ...
Kura Oncology sets investor webcast to discuss Caspian Therapeutics launch and KO-7246 preclinical data
Kura Oncology has announced an investor webcast scheduled for October 13 at 4:30 p.m. ET to discuss the formation and launch of Caspian Therapeutics and to review preclinical data for KO-7246 ...
Kura Oncology teams with Caspian Therapeutics on new diabetes research findings
Kura Oncology announced new preclinical data from its next generation menin inhibitor in collaboration with Caspian Therapeutics, targeting diabetes. The findings were presented at the 62nd ...
Kura Oncology launches Caspian Therapeutics to advance menin inhibitors
Kura Oncology has announced the launch of Caspian Therapeutics, a new separately financed company focused on the development of small-molecule menin inhibitors for diabetes and cardiometabolic ...
Jennifer Fulk appointed as CFO at Kura Oncology
Kura Oncology has appointed Jennifer Fulk as its new chief financial officer. The company said Fulk brings over 20 years of financial and operational leadership experience from the ...
Kura Oncology joins three major investor conferences in September
Kura Oncology announced its participation in three prominent investor conferences scheduled for September. The company will attend the Wells Fargo 21st Annual Healthcare Conference on September ...
Connect to Cures event builds blood cancer community ties as Kura Oncology attends
Kura Oncology participated in the Connect to Cures program hosted by HealthTree in Pittsburgh over the weekend. The event gathered academic and community physicians with the goal of fostering ...
Kura Oncology builds patient centered culture under operational leadership
Kura Oncology is reaffirming its commitment to patient centricity, as emphasized by Chief Operating Officer Kathy Ford. The company credits its strong organizational culture to a purpose driven ...
Kura Oncology delivers financial update as clinical development momentum builds
Kura Oncology has released its Q2 2026 financial results alongside a business update, emphasizing continued progress in its clinical pipeline. The company highlighted advancements in targeted ...
Kura Oncology affirms unique company culture driven by global team
Kura Oncology underscores that great science at the company is rooted in the strength and diversity of its people. Tayla Parker Shen, Associate Director of Global Program Management at Kura ...
Cover feature in Blood boosts Kura Oncology acute myeloid leukemia research visibility
Kura Oncology has secured a notable feature on the cover of the latest issue of Blood, underscoring the recently published research conducted by its investigative team. This publication ...
Kura Oncology hosts Girls Who Lead event for 24 San Diego students
Kura Oncology partnered with Generation STEAM to organize a Girls Who Lead event, welcoming 24 high school students to its San Diego office. The event provided a day filled with discovery, ...
Kura Oncology builds collaborative environment to boost employee growth
Kura Oncology is attracting talent by fostering a collaborative and mission-driven workplace culture. According to Maggie Laughlin, Senior Director and Human Resources Business Partner, the ...
Kura Oncology unveils new kidney cancer data at Boston research summit
Kura Oncology is participating in the Kidney Cancer Research Summit in Boston, where the company is connecting with researchers, clinicians, advocates, and industry partners to foster advancements ...
Kura Oncology restarts activity as team returns from summer break
Kura Oncology has announced that its team is back at work following a week-long annual summer shutdown. The company described the break as a chance for employees to reconnect with family, explore ...
Kura Oncology partners with Victory Programs to support Boston communities facing homelessness and illness
Kura Oncology announced a new partnership this week with Victory Programs, a Boston-based nonprofit organization. The collaboration aims to provide support and resources for individuals and ...
